We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

USIO:NASDAQUsio, Inc. Analysis

Data as of 2026-06-01 - not real-time

$1.61

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Usio, Inc. (USIO) is trading at $1.61, which is roughly seven times its DCF‑derived fair value of $0.21, implying a potential upside of over 200% if the model were to hold. Technical indicators are mixed: the 20‑day SMA ($1.44) sits above the 50‑day SMA ($1.28) and the price is above both averages, the MACD line is bullish (0.105 vs. signal 0.088), and the RSI sits at 63, suggesting modest momentum but no overbought condition. However, the stock remains near the upper end of its recent range (resistance $1.74) and volatility is extremely high at 75% over the past 30 days, with a beta of ~1.02, indicating price swings that mirror the broader market.
Fundamentally, USIO shows modest top‑line growth (15.7% YoY revenue increase) but profitability is weak – operating margin is under 1% and net profit margin is negative (-2.4%). The forward P/E of 96.6 dwarfs the industry average of 41.9, and cash flow is thin (free cash flow $0.12 M against total debt $4.87 M). The company carries no dividend, has a negative ROE, and a modest market cap of $44 M, underscoring liquidity concerns. Together, the overvalued pricing, fragile earnings, and high volatility suggest caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD and price above short‑term moving averages
  • High volatility and near‑term resistance at $1.74
  • Negative earnings and weak cash generation

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Forward P/E of 96.6 far above industry norm
  • DCF fair value suggests significant overpricing
  • Continued cash burn and modest revenue growth

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Negative ROE and low profit margins
  • High debt relative to equity and limited cash reserves
  • Elevated volatility and small‑cap liquidity constraints

Key Metrics & Analysis

Financial Health

Revenue Growth15.70%
Profit Margin-2.42%
P/E Ratio96.6
ROE-11.61%
ROA-1.03%
Debt/Equity26.86
P/B Ratio2.5
Op. Cash Flow$1.1M
Free Cash Flow$117.5K
Industry P/E41.9

Technical Analysis

TrendNeutral
RSI63.5
Support$1.16
Resistance$1.74
MA 20$1.44
MA 50$1.28
MA 200$1.37
MACDBullish
VolumeStable
Fear & Greed Index94.07

Valuation

Fair Value$0.21
Target Price$5.58
Upside/Downside246.79%
GradeOvervalued
TypeValue

Risk Assessment

Beta1.02
Volatility75.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.